Literature DB >> 16850265

Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN).

Yongqiang Li1, Nicolas Taulier, Andrew M Rauth, Xiao Yu Wu.   

Abstract

PURPOSE: The thermodynamics and solid state properties of components and their interactions in a formulation for polymer-lipid hybrid nanoparticles (PLN) were characterized for screening lead lipid carriers and rational design of PLN.
METHODS: Verapamil HCI (VRP) was chosen as a model drug and dextran sulfate sodium (DS) as a counter-ionic polymer. Solubility parameters of VRP, VRP-DS complex, and various lipids were calculated and partition of VRP and VRP-DS in lipids was determined. Thermodynamics of VRP binding to DS was determined by isothermal titration calorimetry (ITC). The solid state properties of individual components and their interactions were characterized using differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD).
RESULTS: Dodecanoic acid (DA) was identified as the best lipid carrier among all lipids tested based on the solubility parameters and partition coefficients. VRP-DS complexation was a thermodynamically favorable process. Maximum binding capacity of DS and the highest drug loading capacity of DA were obtained at an equal ionic molar ratio of DS to VRP. In the PLN formulation, DA remained its crystal structure but had a slightly lower melting point, while VRP-DS complex was in an amorphous form.
CONCLUSIONS: Drug loading efficiency and capacity of a lipid matrix depend on the VRP-DS binding and the interactions of the complex with the lipid. A combined analysis of solubility parameters and partition coefficients is useful for screening lipid candidates for PLN preparation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16850265     DOI: 10.1007/s11095-006-9033-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.

Authors:  C Freitas; R H Müller
Journal:  Eur J Pharm Biopharm       Date:  1999-03       Impact factor: 5.571

Review 2.  Solid lipid nanoparticles: production, characterization and applications.

Authors:  W Mehnert; K Mäder
Journal:  Adv Drug Deliv Rev       Date:  2001-04-25       Impact factor: 15.470

Review 3.  Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles.

Authors:  Paul M Bummer
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2004       Impact factor: 4.889

4.  Association of the minor groove binding drug Hoechst 33258 with d(CGCGAATTCGCG)2: volumetric, calorimetric, and spectroscopic characterizations.

Authors:  Feixue Han; Nicolas Taulier; Tigran V Chalikian
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

5.  Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

Authors:  Roberta Cavalli; M Rosa Gasco; Patrizia Chetoni; Susi Burgalassi; M Fabrizio Saettone
Journal:  Int J Pharm       Date:  2002-05-15       Impact factor: 5.875

6.  Solubility parameters as predictors of miscibility in solid dispersions.

Authors:  D J Greenhalgh; A C Williams; P Timmins; P York
Journal:  J Pharm Sci       Date:  1999-11       Impact factor: 3.534

7.  Partial solubility parameters of poly(D,L-lactide-co-glycolide).

Authors:  S Schenderlein; M Lück; B W Müller
Journal:  Int J Pharm       Date:  2004-11-22       Impact factor: 5.875

8.  Comparison of wax and glyceride solid lipid nanoparticles (SLN).

Authors:  V Jenning; S Gohla
Journal:  Int J Pharm       Date:  2000-03-10       Impact factor: 5.875

9.  Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

Authors:  A zur Mühlen; C Schwarz; W Mehnert
Journal:  Eur J Pharm Biopharm       Date:  1998-03       Impact factor: 5.571

10.  Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers.

Authors:  Ho Lun Wong; Reina Bendayan; Andrew Mike Rauth; Xiao Yu Wu
Journal:  J Pharm Sci       Date:  2004-08       Impact factor: 3.534

View more
  11 in total

1.  The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly.

Authors:  William M Payne; Denis Svechkarev; Alexander Kyrychenko; Aaron M Mohs
Journal:  Carbohydr Polym       Date:  2017-11-08       Impact factor: 9.381

2.  Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.

Authors:  Taksim Ahmed; Fuh-Ching Franky Liu; Chungsheng He; Azhar Z Abbasi; Ping Cai; Andrew M Rauth; Jeffery T Henderson; Xiao Yu Wu
Journal:  Pharm Res       Date:  2021-10-15       Impact factor: 4.200

Review 3.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 4.  Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.

Authors:  Rui Xue Zhang; Ho Lun Wong; Hui Yi Xue; June Young Eoh; Xiao Yu Wu
Journal:  J Control Release       Date:  2016-06-08       Impact factor: 9.776

Review 5.  Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.

Authors:  Rui Xue Zhang; Jason Li; Tian Zhang; Mohammad A Amini; Chunsheng He; Brian Lu; Taksim Ahmed; HoYin Lip; Andrew M Rauth; Xiao Yu Wu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

6.  Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.

Authors:  Alexandre Cc Vieira; Luíse L Chaves; Marina Pinheiro; Domingos Ferreira; Bruno Sarmento; Salette Reis
Journal:  Int J Nanomedicine       Date:  2016-06-03

7.  Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.

Authors:  Guixia Ling; Tianhong Zhang; Peng Zhang; Jin Sun; Zhonggui He
Journal:  Int J Nanomedicine       Date:  2016-08-23

8.  Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation.

Authors:  Arshad Ali Khan; Ibrahim M Abdulbaqi; Reem Abou Assi; Vikneswaran Murugaiyah; Yusrida Darwis
Journal:  Nanoscale Res Lett       Date:  2018-10-15       Impact factor: 4.703

Review 9.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21

10.  Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride.

Authors:  M Shah; Y K Agrawal; K Garala; A Ramkishan
Journal:  Indian J Pharm Sci       Date:  2012-09       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.